Skip to main content
ACRS $3.48 -0.57%
ACRS logo
ACRS · Aclaris Therapeutics, Inc.
Track ACRS — free
$3.48 -0.02 (-0.57%) Q1 2024 earnings call transcript
Market Cap
$555.14M
Shares
158.61M
Volume · Nov 19 1.89M Avg daily vol (3M) 3.05M
All webcasts

Earnings call · FY2026 Q1

Aclaris Therapeutics, Inc. (ACRS) Q1 2026 Earnings Call

NoCallHeld Apr 28, 2026
Apr 28, 2026
Period
FY2026 Q1
Runtime
—
Sources
3 artifacts
Revenue $2.00M +37.2% YoY
Diluted EPS -$0.15
Gross margin · derived Q4 80.2% +15.0 pp YoY
Net income -$19.82M
Open full screen 8-K 8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 8-K call announcement, 10-Q stay in one workspace.

Research coverage

3 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

License And Service$1.46M +44.5% YoY
Laboratory Research Revenue$537,000 +20.7% YoY
Full-screen source Call document